Insights From AMCP

Interview

Key Pharmaceutical Pipeline Developments: Insights from Industry Experts

05/29/2024

Leslie Fish, RPh, Senior Vice President of Clinical Pharmacy, IPD Analytics, LLC

Jeffrey Casberg, MS, RPh, IPD, Vice President of Clinical Pharmacy, IPD Analytics, LLC

Learn about promising drugs currently in the pharmaceutical pipeline and the impact of FDA interventions from presenters at AMCP 2024.

Learn about promising drugs...

05/29/2024

First Report Managed Care

Melissa Andel, Principal, CommonHealth Solutions, LLC

Videos

Navigating the Impact of the Inflation Reduction Act: Implications for Payers, Patients, and Manufacturers

05/24/2024

Melissa Andel, Principal, CommonHealth Solutions, LLC

Learn about the impacts of the Inflation Reduction Act on payers and patients, highlighting the changes in Medicare benefits and drug coverage coming in 2025 and 2026.

Learn about the impacts of the...

05/24/2024

First Report Managed Care

Interview

Leveraging Pharmacists to Resolve Social Determinants of Health Barriers and Improve Patient Outcomes

05/24/2024

Meron Gartner, PharmD, Senior Product Manager, Payer Products, Outcomes

Guest expert and AMCP 2024 presenter Meron Gartner, PharmD, elaborates on how pharmacists play a crucial role in addressing social determinants of health by engaging with patients, identifying barriers, and connecting them to resources for...

Guest expert and AMCP 2024...

05/24/2024

First Report Managed Care

Interview

Improving Patient Engagement in Managed Care Pharmacy Through Collaboration

05/21/2024

Sarah Emond, MPP, President and Chief Executive Officer, ICER

Patient perspectives play a crucial role in shaping healthcare decisions, and AMCP 2024 session speaker Sarah Emond discusses the importance of patient engagement in drug value assessments within the managed care framework, providing examples...

Patient perspectives play a...

05/21/2024

First Report Managed Care

Interview

Exploring Future Possibilities of AI in Managed Care Pharmacy Practice

05/20/2024

Joseph Honcz, RPh, MBA

Guest expert and AMCP 2024 session presenter Joseph Honcz, RPh, MBA, explores the current role of AI in managed care, barriers to implementation, and strategies for collaborating with managed care leadership to advance the testing of AI...

Guest expert and AMCP 2024...

05/20/2024

First Report Managed Care

Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP

Videos

Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations

05/15/2024

Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP

Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.

Learn about developments in...

05/15/2024

First Report Managed Care

Conference Coverage

Specialty Pharmaceuticals Pipeline: Biologic and Biosimilar Approvals and Projected Developments

04/29/2024

Hannah Musick

Explore the latest trends and developments in the specialty pharmaceutical pipeline, including key legal matters, FDA issues, notable approvals, and potential biosimilar savings projected for the next decade as shared in a 2024 AMCP session.

Explore the latest trends and...

04/29/2024

First Report Managed Care

Conference Coverage

Pharmaceutical Industry Trend and Prediction Highlights from AMCP 2024

04/26/2024

Hannah Musick

A keynote session at AMCP 2024 outlined pharmaceutical industry trends and predictions for pharmacy benefits management (PBMs), including challenges and disruptors like the Inflation Reduction Act (IRA), changing consumer preferences, rising...

A keynote session at AMCP 2024...

04/26/2024

First Report Managed Care

Conference Coverage

Strategies for Harnessing AI to Improve Managed Care

04/18/2024

Hannah Musick

During a panel discussion at AMCP 2024, Sean Jeffery, PharmD, BCGP, FASCP, AGSF, Jay Rajda, MD, MBA, Shawn Wang, Chief AI Officer at Elevance Health, and Joseph Honcz, RPh, MBA, detailed case studies to examine the current and future...

During a panel discussion at...

04/18/2024

First Report Managed Care

Conference Coverage

A Global Perspective on the Development of Value-Based Care and Innovative Contracting

04/18/2024

Hannah Musick

Global trends in pharmaceutical pricing strategies and innovative contracting models, the increasing complexities of drug pricing, and the potential risks of an overinflated market bubble were discussed in a keynote session with Omar Ali,...

Global trends in pharmaceutical...

04/18/2024

First Report Managed Care

Conference Coverage

PBM Legislation: Navigating Congressional Delays and Encouraging Progress

04/17/2024

Hannah Musick

Explore the world of federal pharmacy benefit manager (PBM) legislation and its potential impact on stakeholders in this in-depth analysis presented by Ross Margulies, JD, MPH, Partner and Co-Chair Healthcare and Life Sciences Coverage &...

Explore the world of federal...

04/17/2024

First Report Managed Care

Conference Coverage

Understanding the Mechanics of Medicare and Beneficiary Challenges

04/17/2024

Hannah Musick

Sean Chitwood, PharmD, MBA, Clinical Pharmacist, Medicare Stars & Clinical Quality, Government Programs at OptumRx, and Justin Bioc, PharmD, BCPS, BCGP, RPh, Head of Clinical Pharmacy at Devoted Health explored the complexities and nuances of...

Sean Chitwood, PharmD, MBA,...

04/17/2024

First Report Managed Care

Conference Coverage

Multi-Year Educational Initiative Aims to Expand Understanding of Atopic Dermatitis for Managed Care Professionals

04/11/2024

Hannah Musick

An educational initiative aiming to improve access to high-quality care for individuals with atopic dermatitis by expanding managed care professionals' understanding of this condition will be presented at AMCP 2024.

An educational initiative aiming...

04/11/2024

First Report Managed Care

Conference Coverage

Real-World Treatment Barriers for Patients With Chronic Idiopathic Constipation

04/11/2024

Hannah Musick

New research to be presented at AMCP 2024 sheds light on the challenges faced by patients with chronic idiopathic constipation in accessing and affording medication, highlighting the need for improved awareness and insurance coverage.

New research to be presented at...

04/11/2024

First Report Managed Care

Conference Coverage

The True Cost of Nonalcoholic Steatohepatitis Progression

04/11/2024

Hannah Musick

“These data show that the burden of care for NASH is substantial, and compared with those without progression, the annual costs per person with progression are at least 2-fold higher, with the gap increasing over time,” said researchers that...

“These data show that the burden...

04/11/2024

First Report Managed Care

Conference Coverage

Uncovering the Impact of Health Inequalities on Clinical Outcomes in Patients With Lung Disease

04/10/2024

Hannah Musick

Research that will be presented at AMCP 2024 reveals significant disparities in resource use and clinical outcomes for US patients with pneumonia, COPD, and lung cancer, highlighting the impact of health inequalities on access to care and...

Research that will be presented...

04/10/2024

First Report Managed Care

Conference Coverage

Mepolizumab Treatment May Reduce Health Care Resource Utilization and OCS in Patients With CRSwNP

04/10/2024

Hannah Musick

Research that will be presented at AMCP 2024 suggests that mepolizumab treatment reduces health care costs and resource utilization in patients with chronic rhinosinusitis with nasal polyps.

Research that will be presented...

04/10/2024

First Report Managed Care

Conference Coverage

Exploring the Biosimilar Regulatory Landscape and Future Marketplace Potential

04/14/2023

Hannah Musick

Presenters at AMCP 2023 examined the regulatory landscape of biosimilars in the United States, explored key influencers for the adoption, and outlined the practical considerations for use.

Presenters at AMCP 2023 examined...

04/14/2023

First Report Managed Care

Interview

Switching to Biosimilars Yields Significant Cost Savings For Patients Taking Insulin

04/13/2023

Maria Asimopoulos

Courtney Quinn, PharmD, PGY1 pharmacy resident, Navitus Health Solutions, examined potential cost saving trends if individuals enrolled in 4 large commercial health plans switched from reference product insulin glargine to biosimilars.

Courtney Quinn, PharmD, PGY1...

04/13/2023

First Report Managed Care

Conference Coverage

Real-World Strategies for Implementing Biosimilars

04/12/2023

Hannah Musick

Speakers at AMCP 2023 discussed the current landscape of biosimilars from a payer perspective as well as lessons learned from health system biosimilar adoption.

Speakers at AMCP 2023 discussed...

04/12/2023

First Report Managed Care

Conference Coverage

Significant Financial Burden Associated With First-Line Urothelial Carcinoma Therapy

04/11/2023

Hannah Musick

More than half of Medicare members with urothelial carcinoma who received first-line systemic therapy experienced an adverse event, researchers found.

More than half of Medicare...

04/11/2023

First Report Managed Care

Conference Coverage

Expanded NGS Biomarker Testing for Metastatic Colorectal Cancer Could Optimize Treatment With Manageable Costs

04/11/2023

Maria Asimopoulos

Increasing next-generation sequencing testing for metastatic colorectal cancer may help optimize therapy selection without significantly increasing costs for US payers, researchers said.

Increasing next-generation...

04/11/2023

First Report Managed Care

Conference Coverage

Risdiplam May Reduce HCRU, Disease-Related Complications in Patients With SMA

03/29/2023

Hannah Musick

Researchers explored health care resource utilization and outcomes among patients with spinal muscular atrophy to discover the potential benefits of risdiplam therapy.

Researchers explored health care...

03/29/2023

First Report Managed Care

Conference Coverage

How Payers Can Address Barriers to Real-Time Benefit Check Adoption

03/24/2023

Maria Asimopoulos

The session highlighted key obstacles to real-time benefit check adoption by providers and included advice for payers to overcome barriers.

The session highlighted key...

03/24/2023

First Report Managed Care

Conference Coverage

Uncovering the Racial Expenditure Disparities in Patients With Colorectal Cancer

03/22/2023

Hannah Musick

Investigators at AMCP 2023 found the health care expenditure for African American and Hispanic patients with colorectal cancer was substantially lower than that of White patients.

Investigators at AMCP 2023 found...

03/22/2023

First Report Managed Care

Conference Coverage

Adopting a Patient-Focused Approach to Prior Authorization Criteria

03/22/2023

Maria Asimopoulos

In a session at AMCP 2023, speakers shared the rationale driving current prior authorization practices, as well as how health plans might adopt a more patient-focused approach.

In a session at AMCP 2023,...

03/22/2023

First Report Managed Care

Conference Coverage

How the Accelerated Approval Pathway Impacts Rare Diseases, Cancer, and Alzheimer Disease

03/22/2023

Edan Stanley

Speakers at AMCP 2023 offered insight into the accelerated approval pathway's design and how drugs approved through this pathway impact managed care considerations for a variety of disease states.

Speakers at AMCP 2023 offered...

03/22/2023

First Report Managed Care

Conference Coverage

Federal Legislative Updates: PDTs, Performance-based Reimbursement, and More

03/22/2023

Edan Stanley

Presenters at AMCP 2023 reviewed recent prescription digital therapeutics legislation as well as new proposals anticipated to arrive in the next year.

Presenters at AMCP 2023 reviewed...

03/22/2023

First Report Managed Care

Conference Coverage

Immunotherapy Cost Savings Greater With Atezolizumab vs Pembrolizumab for NSCLC

03/21/2023

Maria Asimopoulos

Investigators compared the budget impact associated with maintaining atezolizumab as a preferred treatment option vs increasing the market share of pembrolizumab.

Investigators compared the...

03/21/2023

First Report Managed Care

Conference Coverage

Costs, HCRU Higher With Valbenazine Than Deutetrabenazine for Tardive Dyskinesia

03/20/2023

Hannah Musick

"Further investigation on movement disorder diagnoses codes and variations in provider specialty backgrounds may help elucidate factors that may be driving the differences in health care resource use," investigators said.

"Further investigation on...

03/20/2023

First Report Managed Care

Conference Coverage

Hepatitis Delta Diagnosis Associated With Significant Uptick in HCRU

03/20/2023

Hannah Musick

In light of their findings, researchers advised more effective strategies for hepatitis D screening, diagnosis, and treatment to generate cost savings.

In light of their findings,...

03/20/2023

First Report Managed Care

Insights From AMCP

Specialties

Events

Year Round Education

HMP Global Products